Shire plc (ADR) (NASDAQ:SHPG)

Medicine pills

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Ever since the Hillary Clinton high drug price tweet in September of last year, the major pharmaceuticals and biotechs have struggled, and while performance has improved over the past quarter, ...
Read Full Story »
blue eye

Shire Gains Key FDA Approval in Dry Eye Treatment

Shire PLC (NASDAQ: SHPG) made waves Tuesday morning following a key U.S. Food and Drug Administration (FDA) approval. The company announced that the FDA has approved Xiidra (lifitegrast ophthalmic solution) 5%, ...
Read Full Story »
Pills and tablets

Pfizer and Shire Move on IBD License Agreement

Pfizer Inc. (NYSE: PFE) made waves early on Tuesday after the announcement of its newest licensing deal. Shire PLC (NASDAQ: SHPG) announced it has agreed to license global rights to all indications ...
Read Full Story »
buy now

4 Top Jefferies Value Stocks to Buy With Big Upside Potential

Despite last Friday's meager payroll gains, most of Wall Street seems to be taking the low number as an anomaly and looking at overall brighter economic news. That was the case as ...
Read Full Story »
ThinkstockPhotos-475472230

Top Analyst Upgrades and Downgrades: Alibaba, ADM, CSC, Infosys, Microsoft, Wells Fargo, WisdomTree and More

Stocks were indicated higher on Thursday, after gains on Tuesday and Wednesday were handy. Oil also crossed back above the $50 barrier again for the first time since October 2015. ...
Read Full Story »
white pills

Biotech and Pharmaceuticals Highlight Jefferies Top Growth Stock Buys

With earnings season hitting its stride this week, many investors are looking to see how the companies they own perform. Two areas that have lagged all year long are biotech ...
Read Full Story »
Pills and tablets

What to Expect From Baxalta Q4 Earnings

Baxalta Inc. (NYSE: BXLT) is scheduled to report fourth-quarter and full-year results before markets open on Tuesday. The hematology and immunology focused biopharmaceutical company is expected to post earnings per ...
Read Full Story »
automatic inspection machine

6 Biotech and Pharma Stocks Analysts Want You to Buy Now

The end of 2015 and the start of 2016 have been hard on biotech, and in some cases have been hard for Big Pharma. It turns out that there is ...
Read Full Story »
ThinkstockPhotos-475472230

Top Analyst Upgrades and Downgrades: Akamai, BBVA, Dean Foods, SolarCity, Valero and Many More

Stocks got a big boost on news that Janet Yellen is talking down the Federal Reserve's desire to hike interest rates no matter what. Investors in 2016 have used rallies ...
Read Full Story »
analysis

Top Analyst Upgrades and Downgrades: Best Buy, 3D Systems, EA, Gilead, Nokia, Shire, United Rentals and Many More

Stocks bounced on Thursday, but Friday's early trading indications were looking for a sharp sell-off of almost 2%, based on more oil and China weakness. This is also ahead of ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Apple, BHP Billiton, CA, CarMax, Dean Foods, Freeport-McMoRan, Newmont, Shire, Wells Fargo and Many More

Stocks tried to stabilize on Monday, and Tuesday's early indications were for Dow and S&P 500 futures to be up almost 1%. Last week's sell-off may have been the worst ...
Read Full Story »
Medical interface

Top Cowen Health Care and Biotech Best Idea Stock Picks for 2016

It’s that time of year again, the time when all the top firms that we cover here at 24/7 Wall St. start to make their stock picks and prognostications for ...
Read Full Story »
Pills and tablets

Dyax Agrees to $5.9 Billion Buyout

U.K.-based drugmaker Shire PLC (NASDAQ: SHPG) and Dyax Corp. (NASDAQ: DYAX) announced Monday morning that former will acquire latter for $37.30 in cash per share of Dyax for a total ...
Read Full Story »
ThinkstockPhotos-485280926

The Strongest Performing Biotech in 2015 Is a Surprise

Biotech is still in a rut for 2015, with stocks year to date being essentially unchanged. Since January 1, the Biotechnology Index is up only 0.3%, pretty much breakeven. While ...
Read Full Story »
investing

SunTrust Has Q4 Portfolio ‘Catch-Up’ Stocks to Buy Now

Portfolio managers and others in charge of investments are facing the first down year in the markets since 2008. What can be even worse for active managers is trailing your ...
Read Full Story »